Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period

Hospitalization for acute heart failure (HF) is associated with a substantial morbidity burden and with associated healthcare costs and an increased mortality risk. However, few if any major medical innovations have been witnessed in this area in recent times. Levosimendan is a first‐in‐class calciu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:ESC Heart Fail
Autori principali: Pölzl, Gerhard, Allipour Birgani, Shadab, Comín‐Colet, Josep, Delgado, Juan F., Fedele, Francesco, García‐Gonzáles, Martín Jesús, Gustafsson, Finn, Masip, Josep, Papp, Zoltán, Störk, Stefan, Ulmer, Hanno, Vrtovec, Bojan, Wikström, Gerhard, Altenberger, Johann
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Study Designs
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6351894/
https://ncbi.nlm.nih.gov/pubmed/30378288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12366
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi